AZN (AstraZeneca) Cash Flow for Dividends : $-4,629 Mil (TTM As of Dec. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Cash Flow for Dividends?

AstraZeneca's cash flow for dividends for the three months ended in Dec. 2024 was $-3 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $-4,629 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

AstraZeneca's quarterly payment of dividends increased from Jun. 2024 ($-17 Mil) to Sep. 2024 ($-1,576 Mil) but then declined from Sep. 2024 ($-1,576 Mil) to Dec. 2024 ($-3 Mil).

AstraZeneca's annual payment of dividends increased from Dec. 2022 ($-4,364 Mil) to Dec. 2023 ($-4,481 Mil) and increased from Dec. 2023 ($-4,481 Mil) to Dec. 2024 ($-4,629 Mil).

AstraZeneca Cash Flow for Dividends Historical Data

The historical data trend for AstraZeneca's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Cash Flow for Dividends Chart

AstraZeneca Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-3,572.00

-3,856.00

-4,364.00

-4,481.00

-4,629.00

AstraZeneca Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-2.00	-3,033.00	-17.00	-1,576.00	-3.00

AstraZeneca Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4,629 Mil.

AstraZeneca Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZN1:Mexico AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil AZN:Argentina

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.